IL136962A0 - Combination therapy for the treatment of migraine - Google Patents
Combination therapy for the treatment of migraineInfo
- Publication number
- IL136962A0 IL136962A0 IL13696200A IL13696200A IL136962A0 IL 136962 A0 IL136962 A0 IL 136962A0 IL 13696200 A IL13696200 A IL 13696200A IL 13696200 A IL13696200 A IL 13696200A IL 136962 A0 IL136962 A0 IL 136962A0
- Authority
- IL
- Israel
- Prior art keywords
- migraine
- treatment
- combination therapy
- therapy
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14168099P | 1999-06-30 | 1999-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL136962A0 true IL136962A0 (en) | 2001-06-14 |
Family
ID=22496730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13696200A IL136962A0 (en) | 1999-06-30 | 2000-06-22 | Combination therapy for the treatment of migraine |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20030216458A1 (es) |
| EP (1) | EP1064948A3 (es) |
| JP (1) | JP2001031568A (es) |
| KR (1) | KR20010066886A (es) |
| AU (1) | AU4271100A (es) |
| CA (1) | CA2312633A1 (es) |
| CO (1) | CO5190678A1 (es) |
| HU (1) | HUP0002508A3 (es) |
| IL (1) | IL136962A0 (es) |
| PE (1) | PE20010513A1 (es) |
| ZA (1) | ZA200003235B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8022095B2 (en) | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| US20020077328A1 (en) * | 2000-07-13 | 2002-06-20 | Fred Hassan | Selective cyclooxygenase-2 inhibitors and vasomodulator compounds for generalized pain and headache pain |
| WO2002017896A2 (en) * | 2000-08-29 | 2002-03-07 | Peter Van Patten | Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid |
| MXPA05006954A (es) | 2002-12-26 | 2005-09-22 | Pozen Inc | Formas de dosificacion de capas multiples que contienen nsaids y triptanos. |
| NL2000351C2 (nl) | 2005-12-22 | 2007-09-11 | Pfizer Prod Inc | Estrogeen-modulatoren. |
| AU2009260166B2 (en) | 2008-06-20 | 2014-10-09 | Alphapharm Pty Ltd | Pharmaceutical formulation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
| US5872145A (en) * | 1996-08-16 | 1999-02-16 | Pozen, Inc. | Formulation of 5-HT agonist and NSAID for treatment of migraine |
| US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
| CN1145486C (zh) * | 1997-07-03 | 2004-04-14 | 美国辉瑞有限公司 | 含eletriptan半硫酸盐和咖啡因的药用组合物 |
-
2000
- 2000-06-16 CO CO00045172A patent/CO5190678A1/es unknown
- 2000-06-22 IL IL13696200A patent/IL136962A0/xx unknown
- 2000-06-26 EP EP00305352A patent/EP1064948A3/en not_active Withdrawn
- 2000-06-26 PE PE2000000638A patent/PE20010513A1/es not_active Application Discontinuation
- 2000-06-27 AU AU42711/00A patent/AU4271100A/en not_active Abandoned
- 2000-06-28 ZA ZA200003235A patent/ZA200003235B/xx unknown
- 2000-06-28 CA CA002312633A patent/CA2312633A1/en not_active Abandoned
- 2000-06-29 HU HU0002508A patent/HUP0002508A3/hu unknown
- 2000-06-30 KR KR1020000036795A patent/KR20010066886A/ko not_active Ceased
- 2000-06-30 JP JP2000197648A patent/JP2001031568A/ja active Pending
-
2003
- 2003-04-09 US US10/410,664 patent/US20030216458A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU4271100A (en) | 2001-01-04 |
| KR20010066886A (ko) | 2001-07-11 |
| CA2312633A1 (en) | 2000-12-30 |
| EP1064948A3 (en) | 2003-01-08 |
| EP1064948A2 (en) | 2001-01-03 |
| CO5190678A1 (es) | 2002-08-29 |
| ZA200003235B (en) | 2002-01-02 |
| PE20010513A1 (es) | 2001-04-21 |
| JP2001031568A (ja) | 2001-02-06 |
| HUP0002508A3 (en) | 2001-07-30 |
| US20030216458A1 (en) | 2003-11-20 |
| HUP0002508A2 (hu) | 2001-05-28 |
| HU0002508D0 (en) | 2000-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL164599A0 (en) | Combination therapy for the treatment of cancer | |
| AU2002350235A1 (en) | Combination bacteriolytic therapy for the treatment of tumors | |
| IL158329A0 (en) | Antiangiogenic combination therapy for the treatment of cancer | |
| EP1077704A4 (en) | COMBINATION THERAPY FOR TREATING DEPRESSION | |
| HUP0500424A2 (en) | Combination therapy for the treatment of cancer | |
| KR100510795B1 (en) | Compositions and Methods for the Treatment of Tumor | |
| IL146697A0 (en) | SELECTIVE iGluR5 RECEPTOR FOR THE TREATMENT OF MIGRAINE | |
| IL136960A0 (en) | Combination therapy for the treatment of migraine | |
| IL162818A0 (en) | Combination therapy for the treatment of bacterialinfections | |
| ZA200110436B (en) | Therapeutic use of melatonin. | |
| AU2001285156A1 (en) | Combination therapy for the treatment of migraine | |
| IL136962A0 (en) | Combination therapy for the treatment of migraine | |
| IL136025A0 (en) | Combination therapy for the treatment of migraine | |
| IL136024A0 (en) | Combination therapy for the treatment of migraine | |
| HUP0100365A3 (en) | Combination therapy for the treatment of aids | |
| GB2363604B (en) | S-nitrosothiols as agents for the treatment of circulatory dsyfunctions | |
| SI1451177T1 (sl) | Substituirani 2-pirolidin-2-il-1H-indolni derivati za zdravljenje migrene | |
| GB9904252D0 (en) | Composition for the treatment of pain | |
| GB9807938D0 (en) | Combination therapy for the treatment of AIDS | |
| GB9819590D0 (en) | Combination therapy for the treatment of aids | |
| KR100511819B1 (en) | Compositions and Methods for the Treatment of Tumor | |
| GB9901505D0 (en) | Therapeutic treatment | |
| GB9924980D0 (en) | Therapeutic treatment | |
| ZA9810306B (en) | Combination therapy for the treatment of aids | |
| KR100512820B1 (en) | Compositions and Methods for the Treatment of Tumor |